BioArctic's Partner Eisai Says Leqembi Approved In Hong Kong For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1183677/bioarctics-partner-eisai-says-leqembi-approved-in-hong-kong-for-alzheimers-disease-treatment

]]>https://dev.proinvestor.com/forum/topic/400888/pharma-juli-2024RSS for NodeSun, 07 Jun 2026 04:31:39 GMTThu, 11 Jul 2024 01:56:16 GMT60Biotech Stocks Facing FDA Decision In August 2024 https://proinvestor.com/investornyt/1191575/biotech-stocks-facing-fda-decision-in-august-2024

]]>https://dev.proinvestor.com/forum/post/8038101https://dev.proinvestor.com/forum/post/8038101Mon, 29 Jul 2024 07:23:20 GMTStorbank løfter kursmål for Lundbeck - ser kurspotentiale på 32 pct. https://proinvestor.com/investornyt/1191551/storbank-lofter-kursmal-for-lundbeck-ser-kurspotentiale-pa-32-pct

]]>https://dev.proinvestor.com/forum/post/8038103https://dev.proinvestor.com/forum/post/8038103Mon, 29 Jul 2024 03:34:13 GMTVideo: I den anden af de tre specials har Per inviteret bestyrelsesformand i ALK-Abelló Anders Hedegaard i studiet. De taler blandt andet om forskellen på at sidde i bestyrelse i Tyskland i forhold til i Danmark, samt om danske bestyrelser er en old boys club. https://proinvestor.com/boards/121469

]]>https://dev.proinvestor.com/forum/post/8038102https://dev.proinvestor.com/forum/post/8038102Wed, 24 Jul 2024 11:50:20 GMT